BLACKMORES EXECUTIVE B (Export

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

thiamine hydrochloride, Quantity: 75 mg; riboflavin, Quantity: 10 mg; nicotinamide, Quantity: 100 mg; pyridoxine hydrochloride, Quantity: 25 mg (Equivalent: pyridoxine, Qty 20.57 mg); calcium ascorbate dihydrate, Quantity: 145 mg (Equivalent: ascorbic acid, Qty 119.77 mg; Equivalent: calcium, Qty 13.63 mg); ascorbic acid, Quantity: 130 mg; d-alpha-tocopheryl acid succinate, Quantity: 41.32 mg (Equivalent: d-alpha-tocopheryl acid succinate, Qty 50 IU); calcium pantothenate, Quantity: 75 mg (Equivalent: pantothenic acid, Qty 68.71 mg; Equivalent: calcium, Qty 6.29 mg); magnesium phosphate pentahydrate, Quantity: 140 mg (Equivalent: magnesium, Qty 28.92 mg); calcium phosphate, Quantity: 100 mg (Equivalent: calcium, Qty 37 mg); cyanocobalamin, Quantity: 30 microgram; Biotin, Quantity: 20 microgram; folic acid, Quantity: 150 microgram; Avena sativa, Quantity: 25 mg (Equivalent: Avena sativa, Qty 250 mg); Passiflora incarnata, Quantity: 20 mg (Equivalent: Passiflora incarnata, Qty 100 mg); lecithin, Quantity: 50 mg; choline bitartrate, Quantity: 25 mg; inositol, Quantity: 25 mg; monobasic potassium phosphate, Quantity: 117.3 mg (Equivalent: potassium, Qty 33.7 mg)

Dostępny od:

Blackmores Ltd

Forma farmaceutyczna:

Tablet, film coated

Skład:

Excipient Ingredients: microcrystalline cellulose; croscarmellose sodium; ethylcellulose; purified talc; colloidal anhydrous silica; magnesium stearate; macrogol 8000; hypromellose; macrogol 400; iron oxide red; iron oxide yellow; iron oxide black; titanium dioxide; Carnauba Wax; silicon dioxide; tartaric acid

Droga podania:

Oral

Podsumowanie produktu:

Visual Identification: Mottled dark cream to yellow large oval shaped tablet, coated dark brown.; Container Type: Bottle

Status autoryzacji:

Listed (Export Only)

Data autoryzacji:

2020-11-02